Doctors lead drive to bring down waiting times and improve outcomes

Three top doctors at Barts Health NHS Trust are leading a drive to bring down waiting times and improve outcomes.

(c) Barts Health NHS Trust

(c) Barts Health NHS Trust

Nick Aresti (trauma and orthopaedics), James Green (urology) and Funlayo Odejinmi (gynaecology) are the clinical leads for the 12-month pilot operational delivery networks to ensure more patients get swifter access to routines surgery across the trust's group of hospitals.

Simon Ashton, chief executive of Newham hospital, said: ‘Surgery saves lives but is also complex and risky. Surgeons perform at their best when they do large numbers of operations of the same sort in the same place. The scientific evidence shows that consolidating surgery in specialist centres means better outcomes, more consistent clinical standards, and shorter hospital stays.'

With support from the respective hospital chief executives and operational teams, each consultant will oversee efforts to make the most of the available capacity for each specialty across all the trust's hospitals, including sharing information and harmonising practices to achieve common standards so patients get the best possible treatment in the most appropriate place.

A key objective for each network is to find an effective and equitable cross-site way to manage the waiting list for that speciality and reduce variations. 

The orthopaedic clinical network is already leading the way by consolidating much routine day surgery for bones and joints at the Barts Health Orthopaedic Centre in Newham.   

New surgical elective centre to help tackle waiting lists

New surgical elective centre to help tackle waiting lists

By Lee Peart 26 November 2025

A new surgical elective centre (SEC) designed to tackle improve care and tackle waiting lists has reached a construction milestone.

Waiting list target will be missed unless models of care change, doctors warn

By Lee Peart 25 November 2025

The Government will not reach its 18-week target if current levels of care remain unchanged, according to the Royal College of Physicians (RCP).

Personalised 'living drug' for aggressive leukaemia to become available on NHS

By Liz Wells 25 November 2025

An immunotherapy for patients with an aggressive form of leukaemia is to be made available on the NHS after 77% of patients went into remission during trials.


Popular articles by Lee Peart